Showing results (231-240 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|March 17, 2023
Pathway Alterations in Stage II/III Primary MelanomaCaroline E Kostrzewa, Li Luo, Arshi Arora, et al.
JCO Precision Oncology|March 2, 2023
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid TumorsMihaela Aldea, Marco Tagliamento, Arnaud Bayle, et al.
JCO Precision Oncology|March 23, 2023
Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center StudyTrisha Larkin, Reema Kashif, Abdelrahman H Elsayed, et al.
JCO Precision Oncology|December 5, 2025
Impact of RAS-MAPK Pathway Genetic Alterations on Radiotherapy Response in Metastatic Lung AdenocarcinomaGustav Y Cederquist, Erik S Anderson, Eric Lis, et al.
JCO Precision Oncology|December 5, 2025
Clinical Utility of Multicancer Detection in Symptomatic Patients: A Decision-Making PerspectiveGiuliano Netto Flores Cruz, Keegan Korthauer
JCO Precision Oncology|December 10, 2025
Long Short-Term Memory-Driven Modeling of Dynamic Hepatocellular Carcinoma Microenvironments: A Deep Learning Framework for Precision Treatment PredictionHai Zhong, Bin Wu, Xiaodan Yang, et al.
JCO Precision Oncology|August 13, 2020
Pediatric Somatic Tumor Sequencing Identifies Underlying Cancer PredispositionSuzanne P MacFarland, Kristin Zelley, Lea F Surrey, et al.
JCO Precision Oncology|September 30, 2021
Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice NeedsJessica Russo, Carey McDougall, Nicholas Bowler, et al.
JCO Precision Oncology|September 29, 2021
Clinical Implications of Genomic Loss of Heterozygosity in Endometrial CarcinomaBethany Bustamante, Risha Sinha, Briana Rice, et al.
JCO Precision Oncology|September 27, 2021
Impact of Disease Evolution on Efficacy Outcomes From Larotrectinib in Patients With Locally Advanced or Metastatic Tropomyosin Receptor Kinase Fusion-Positive Solid TumorsCarsten Bokemeyer, Gilles Vassal, Antoine Italiano, et al.
Pageof 140